These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22013053)

  • 1. Generation of HIV latency in humanized BLT mice.
    Denton PW; Olesen R; Choudhary SK; Archin NM; Wahl A; Swanson MD; Chateau M; Nochi T; Krisko JF; Spagnuolo RA; Margolis DM; Garcia JV
    J Virol; 2012 Jan; 86(1):630-4. PubMed ID: 22013053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV latency in the humanized BLT mouse.
    Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
    J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.
    Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV
    Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse.
    Choudhary SK; Archin NM; Cheema M; Dahl NP; Garcia JV; Margolis DM
    J Virol; 2012 Jan; 86(1):114-20. PubMed ID: 22013038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.
    Brainard DM; Seung E; Frahm N; Cariappa A; Bailey CC; Hart WK; Shin HS; Brooks SF; Knight HL; Eichbaum Q; Yang YG; Sykes M; Walker BD; Freeman GJ; Pillai S; Westmoreland SV; Brander C; Luster AD; Tager AM
    J Virol; 2009 Jul; 83(14):7305-21. PubMed ID: 19420076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
    Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
    Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.
    Denton PW; Othieno F; Martinez-Torres F; Zou W; Krisko JF; Fleming E; Zein S; Powell DA; Wahl A; Kwak YT; Welch BD; Kay MS; Payne DA; Gallay P; Appella E; Estes JD; Lu M; Garcia JV
    J Virol; 2011 Aug; 85(15):7582-93. PubMed ID: 21593172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.
    Cohen J
    Science; 2005 Aug; 309(5737):999-1000. PubMed ID: 16099956
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
    Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
    PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA.
    Shanmugasundaram U; Kovarova M; Ho PT; Schramm N; Wahl A; Parniak MA; Garcia JV
    PLoS One; 2016; 11(7):e0159517. PubMed ID: 27438728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.
    Marsden MD; Loy BA; Wu X; Ramirez CM; Schrier AJ; Murray D; Shimizu A; Ryckbosch SM; Near KE; Chun TW; Wender PA; Zack JA
    PLoS Pathog; 2017 Sep; 13(9):e1006575. PubMed ID: 28934369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.
    Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR
    Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.